Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000906304-18-000001
Filing Date
2018-01-03
Accepted
2018-01-03 12:43:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 lpcn3.txt SC 13G/A 5809
  Complete submission text file 0000906304-18-000001.txt   7642
Mailing Address 745 FIFTH AVENUE NEW YORK NY 10151
Business Address 745 FIFTH AVENUE NEW YORK NY 10151 212-508-4500
ROYCE & ASSOCIATES LP (Filed by) CIK: 0000906304 (see all company filings)

EIN.: 522343049 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Subject) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87564 | Film No.: 18504188
SIC: 2834 Pharmaceutical Preparations